An interventional study of platelet rich plasma, narrow band UVB in Management of Stable Vitiligo, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 15 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-04-17.
Sponsored by Sohag University · Not applicable, Interventional, and Treatment
For each patient, one side of body will be treated with NB-UVB alone while the other side will be treated with NB-UVB therapy in addition to intradermal injection of PRP every 2 weeks. Patients will be photographed at the first visit, in the middle and at the end of therapy. Each patient will sign a written consent form to be included in the study and to be photographed.
298 studies on the registry are indexed under Vitiligo; 69 are open to participants now.
This study's enrollment of 30 is close to the median of 30 across 227 interventional studies indexed under Vitiligo.
Browse Vitiligo studies →Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with stable non segmental vitiligo. (Absence of koebnerization, absence of new lesion and absence of widening of the existing lesions).
Patients have more than 15 years.
-
Exclusion Criteria:
Patients have active vitiligo (appearance of new lesion, history of koebnerization).
Pregnant and lactating women. History of keloid formation. Anemia (hemoglobin level \<10gm/dl), thrombocytopenia (platelet count \<100,000 /µL), coagulopathies or patients on anticoagulant therapy and patients with iron deficiency.
Patients taking drugs that prolong bleeding time such as Aspirin and vitamin E Patients taking treatment of vitiligo in last 2 months
Procedure: platelet rich plasma, narrow band UVB
Procedure: platelet rich plasma, narrow band UVB
Role of PRP in treating stable vitiligo
Improvement of vitiligo
increase repigmentation score
Time frame: within 6 months
Plan to share: Undecided — Researcher shall pubish in national journal
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sohag University